Sma News & Perspectives
Novartis to Open, at FDA Request, New Trial of Zolgensma for Older Patients
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:07:24
- Mas informaciones
Informações:
Sinopsis
SMA News Today’s multimedia associate, Price Wooldridge, discusses Novartis opening, at FDA request, a new trial of Zolgensma for older patients. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/
